Squalamine Lactate Eye Drops in Combination With Ranibizumab in Patients With Diabetic Macular Edema (DME)
Status:
Withdrawn
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
A randomized, controlled study of the safety and efficacy of Squalamine Lactate Eye Drops in
combination with Ranibizumab intravitreal injections in patients with diabetic macular edema.
The study duration is 52 weeks and patients will be randomized to one of four treatment arms.